STAAR Surgical SG&A Expenses 2010-2023 | STAA
STAAR Surgical sg&a expenses from 2010 to 2023. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
STAAR Surgical Annual SG&A Expenses
(Millions of US $) |
| 2023 |
$180 |
| 2022 |
$144 |
| 2021 |
$111 |
| 2020 |
$80 |
| 2019 |
$75 |
| 2018 |
$63 |
| 2017 |
$48 |
| 2016 |
$50 |
| 2015 |
$43 |
| 2014 |
$44 |
| 2013 |
$43 |
| 2012 |
$39 |
| 2011 |
$34 |
| 2010 |
$32 |
| 2009 |
$30 |
STAAR Surgical Quarterly SG&A Expenses
(Millions of US $) |
| 2023-12-31 |
$39 |
| 2023-09-30 |
$46 |
| 2023-06-30 |
$50 |
| 2023-03-31 |
$44 |
| 2022-12-31 |
$39 |
| 2022-09-30 |
$37 |
| 2022-06-30 |
$38 |
| 2022-03-31 |
$29 |
| 2021-12-31 |
$29 |
| 2021-09-30 |
$29 |
| 2021-06-30 |
$30 |
| 2021-03-31 |
$23 |
| 2020-12-31 |
$21 |
| 2020-09-30 |
$21 |
| 2020-06-30 |
$18 |
| 2020-03-31 |
$19 |
| 2019-12-31 |
$19 |
| 2019-09-30 |
$20 |
| 2019-06-30 |
$19 |
| 2019-03-31 |
$17 |
| 2018-12-31 |
$16 |
| 2018-09-30 |
$17 |
| 2018-06-30 |
$17 |
| 2018-03-31 |
$13 |
| 2017-12-31 |
$13 |
| 2017-09-30 |
$11 |
| 2017-06-30 |
$12 |
| 2017-03-31 |
$12 |
| 2016-12-31 |
$10 |
| 2016-09-30 |
$12 |
| 2016-06-30 |
$12 |
| 2016-03-31 |
$16 |
| 2015-12-31 |
$11 |
| 2015-09-30 |
$11 |
| 2015-06-30 |
$11 |
| 2015-03-31 |
$11 |
| 2014-12-31 |
$10 |
| 2014-09-30 |
$10 |
| 2014-06-30 |
$13 |
| 2014-03-31 |
$12 |
| 2013-12-31 |
$12 |
| 2013-09-30 |
$10 |
| 2013-06-30 |
$10 |
| 2013-03-31 |
$10 |
| 2012-12-31 |
$11 |
| 2012-09-30 |
$10 |
| 2012-06-30 |
$10 |
| 2012-03-31 |
$9 |
| 2011-12-31 |
$9 |
| 2011-09-30 |
$8 |
| 2011-06-30 |
$8 |
| 2011-03-31 |
$8 |
| 2010-12-31 |
$8 |
| 2010-09-30 |
$8 |
| 2010-06-30 |
$8 |
| 2010-03-31 |
$7 |
| 2009-12-31 |
$8 |
| 2009-09-30 |
$7 |
| 2009-06-30 |
$8 |
| 2009-03-31 |
$8 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$2.081B |
$0.322B |
|
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
|
